Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up - The Honolulu Heart Program

被引:49
作者
Madison, JR
Spies, C
Schatz, IJ
Masaki, K
Chen, R
Yano, K
Curb, JD
机构
[1] Univ Hawaii, John A Burns Sch Med, Dept Internal Med, Honolulu, HI 96822 USA
[2] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA
[3] Honolulu Heart Program, Honolulu, HI USA
关键词
D O I
10.1001/archinte.166.8.884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Urinary protein excretion has been linked to coronary heart disease (CHD); the relationship to stroke is less clear. We assessed whether urine dipstick screening for protein predicted stroke and CHD in the Honolulu Heart Program cohort. Methods: Prospective, observational study of 6252 Japanese American men in Honolulu aged 45 to 68 years. Proteinuria was detected by means of urine dipstick screening during the first and third examinations. Subjects were classified as having no proteinuria if results were negative at both examinations, transient proteinuria if results were positive at 1 examination, and persistent proteinuria if results were positive at both examinations. Relative risk was derived using those subjects with no proteinuria as the reference. Outcomes were assessed through 27 years. Results: No proteinuria was found in 92.8% of subjects, transient proteinuria in 6.1%, and persistent proteinuria in 1.1%. The age-adjusted incident stroke rates were 3.7, 7.3, and 11.8 per 1000 person-years in subjects with no, transient, or persistent proteinuria, respectively (P <. 001). Age-adjusted rates of incident CHD were 9.4, 15.8, and 35.2 events per 1000 person-years, respectively (P <. 001). Using Cox proportional hazards models, adjusting for age, body mass index, physical activity, smoking status, cholesterol level, presence of hypertension or diabetes mellitus, and alcohol consumption, the relative risk for 27-year incident stroke was 1.66 (95% confidence interval, 1.21-2.30; P=.002) with transient proteinuria and 2.84 (95% confidence interval, 1.51-5.34; P=. 001) with persistent proteinuria, and relative risk for 27-year incident CHD was 1.48 (95% confidence interval, 1.19-1.83; P <. 001) with transient proteinuria and 3.72 (95% confidence interval, 2.62-5.27; P <. 001) with persistent proteinuria. Conclusion: Proteinuria detected at urine dipstick screening independently predicted increased risk for incident stroke and incident CHD over 27 years in this cohort.
引用
收藏
页码:884 / 889
页数:6
相关论文
共 32 条
[21]  
NAGAI R, 1994, DIPSTICK PROTEINURIA, P436
[22]   EFFECT OF PROTEINURIA ON MORTALITY IN NIDDM [J].
NELSON, RG ;
PETTITT, DJ ;
CARRAHER, MJ ;
BAIRD, HR ;
KNOWLER, WC .
DIABETES, 1988, 37 (11) :1499-1504
[23]   Endothelial dysfunction and inflammation in asymptomatic proteinuria [J].
Paisley, KE ;
Beaman, M ;
Tooke, JE ;
Mohamed-Ali, V ;
Lowe, GDO ;
Shore, AC .
KIDNEY INTERNATIONAL, 2003, 63 (02) :624-633
[24]  
PARVING HH, 1974, LANCET, V1, P1190
[25]   Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition [J].
Remuzzi, G ;
Ruggenenti, P ;
Perico, N .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (08) :604-615
[26]   Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women [J].
Roest, M ;
Banga, JD ;
Janssen, WMT ;
Grobbee, DE ;
Sixma, JF ;
de Jong, PE ;
de Zeeuw, D ;
van der Schouw, YT .
CIRCULATION, 2001, 103 (25) :3057-3061
[27]   MORTALITY FROM CORONARY-HEART-DISEASE AND CEREBROVASCULAR-DISEASE AND ASSOCIATED RISK-FACTORS IN DIABETIC-PATIENTS IN OSAKA DISTRICT, JAPAN [J].
SASAKI, A ;
HORIUCHI, N ;
HASEGAWA, K ;
UEHARA, M .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 27 (01) :77-83
[28]   MORTALITY AND CAUSES OF DEATH IN TYPE-2 DIABETIC-PATIENTS - A LONG-TERM FOLLOW-UP-STUDY IN OSAKA DISTRICT, JAPAN [J].
SASAKI, A ;
HORIUCHI, N ;
HASEGAWA, K ;
UEHARA, M .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1989, 7 (01) :33-40
[29]   PROTEINURIA AND MORTALITY IN DIABETES - THE WHO MULTINATIONAL STUDY OF VASCULAR-DISEASE IN DIABETES [J].
STEPHENSON, JM ;
KENNY, S ;
STEVENS, LK ;
FULLER, JH ;
LEE, E .
DIABETIC MEDICINE, 1995, 12 (02) :149-155
[30]   MORBIDITY, MORTALITY, AND ALBUMINURIA IN TYPE-2 DIABETIC-PATIENTS - A 3 YEAR PROSPECTIVE-STUDY OF A RANDOM COHORT IN GENERAL-PRACTICE [J].
STIEGLER, H ;
STANDL, E ;
SCHULZ, K ;
ROTH, R ;
LEHMACHER, W .
DIABETIC MEDICINE, 1992, 9 (07) :646-653